Challenges in Clinical Trial Design for Advanced NSCLC

Speaker: Federico Cappuzzo

F.Cappuzzo analyses challenges in designing clinical trials to properly take care of the peculiar molecular landscape of NSCLC and the mechanism of action and potential toxicities of new drugs. Ultimate goal: find the most cost-effective treatment for patients.

Discussion Points

  • How is the molecular landscape of non-small-cell lung cancer (NSCLC) peculiar and how does it challenge the current concept of designing clinical trials?
  • Considering the fast pace at which oncology is evolving, what other possible challenge could arise in the design of clinical trials?
  • What is important to consider in designing the next generation of clinical trials for advanced NSCLC?